A new study shows that Black individuals with extensive-stage small cell lung cancer are less likely to receive chemotherapy for their disease compared to white and other racial groups. Led by researchers at Boston Medical ...
Oct 26, 2020
0
1
Despite the increasing use and promise of hematopoietic cell transplantation (HCT) as curative therapy for children with cancer and other life-threatening diseases, new research suggests that children transplanted for cancer ...
Oct 26, 2020
0
4
Plasma taken from the blood of people who have recovered from COVID-19 and given to people sick with the disease does not reduce their chances of getting seriously ill or dying, new research has found.
Oct 23, 2020
2
17
U.S. regulators on Thursday approved the first drug to treat COVID-19: remdesivir, an antiviral medicine given to hospitalized patients through an IV.
Oct 23, 2020
0
3
(HealthDay)—Hispanic mothers-to-be in the southern United States are almost twice as likely to have COVID-19 as non-Hispanic women, a new study finds.
Oct 22, 2020
0
2
Chemotherapy-based cancer treatment has distressing side effects for patients and increases the risk of developing resistance to the treatment. In an attempt to solve these problems, scientists from the University of Geneva ...
Oct 6, 2020
0
5
In general, surgeons who perform numerous cataract operations every year encounter relatively few severe cases, and this probably contributes to their lower complication rate, as shown by a study led from the University of ...
Oct 2, 2020
0
5
(HealthDay)—Since the passage of "Obamacare," fewer Americans are facing insurmountable medical bills—but the benefit does not seem to be reaching people with private insurance, a new study shows.
Sep 30, 2020
0
2
Modifiable health risks, such as obesity, high blood pressure, and smoking, were linked to over $730 billion in health care spending in the US in 2016, according to a study published in The Lancet Public Health. Researchers ...
Sep 30, 2020
0
0
Prices paid to hospitals nationally during 2018 by privately insured patients averaged 247% of what Medicare would have paid, with wide variation in prices among states, according to a new RAND Corporation study.
Sep 18, 2020
0
5
